Printer Friendly

SANDOZ PHARMACEUTICALS: FREE PRESCRIPTION MEDICATION AVAILABLE TO THOSE DISPLACED BY HURRICANE ANDREW

 SANDOZ PHARMACEUTICALS: FREE PRESCRIPTION MEDICATION
 AVAILABLE TO THOSE DISPLACED BY HURRICANE ANDREW
 EAST HANOVER, N.J., Sept. 4 /PRNewswire/ -- The following is a public service announcement from Sandoz Pharmaceuticals:
 If you or a member of your family are taking prescription medications manufactured by Sandoz Pharmaceuticals, this message may be of vital importance. Sandoz Pharmaceuticals of East Hanover, has established a medication assistance program for individuals displaced by Hurricane Andrew. All Sandoz prescription products will be available to those in need -- free of charge until the end of September.
 Ask your pharmacist about this program. For more information, call toll-free 1-800-524-0265.
 -0- 9/4/92
 /CONTACT: Gil Honigfeld of Sandoz Pharmaceuticals, 201-503-8351, or Jerri Ann Yznaga of Rowland Company, 212-527-8884, for Sandoz Pharmaceuticals/ CO: Sandoz Pharmaceuticals Corporation ST: New Jersey, Florida IN: MTC SU:


AH-CK -- NY036 -- 6951 09/04/92 13:02 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 4, 1992
Words:142
Previous Article:/C O R R E C T I O N -- HOECHST-ROUSSEL PHARMACEUTICALS INC.
Next Article:KANSAS BANKER RESIGNS, CONSENTS TO PROHIBITION AND PAYMENT OF $2.7 MILLION LOAN LOSS
Topics:


Related Articles
SANDOZ ANNOUNCES PRICE REDUCTION TO VETERANS ADMINISTRATION, PUBLIC HEALTH SERVICE AND OTHER FEDERAL CLINICS
HOECHST-ROUSSEL PHARMACEUTICALS DONATES MEDICINE TO HELP FLORIDA RECOVERY
SANDOZ PHARMACEUTICALS CORPORATION ISSUES STATEMENT
SANDOZ PHARMACEUTICALS ANNOUNCES MANAGEMENT INITIATIVE
SANDOZ AND MARION MERRELL DOW ANNOUNCE CO-PROMOTION ARRANGEMENT
PRESCRIPTION PROGRAM LIMITS REIMBURSEMENT FOR RESTORIL
PRESCRIPTION PROGRAM LIMITS REIMBURSEMENT FOR RESTORIL
SANDOZ PHARMACEUTICALS CORPORATION AND CLINTRIALS RESEARCH INC. SIGN STRATEGIC ALLIANCE AGREEMENT
CLINTRIALS RESEARCH INC. AND SANDOZ PHARMACEUTICALS CORP. SIGN STRATEGIC ALLIANCE AGREEMENT
MARK A. PULIDO NAMED CHIEF OPERATING OFFICER

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters